Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis

NCT05060250 is registered in ClinicalTrials.gov with Bluejay Diagnostics, Inc. as lead sponsor.

NCT NCT05060250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05060250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis
Lead sponsor
Bluejay Diagnostics, Inc.
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2021
Completion date
December 31, 2024
Enrollment
96 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe sepsis